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GP64 is the major envelope glycoprotein from budded virions of the baculoviruses Autographa californica multicapsid nucle-
opolyhedrovirus (AcMNPV) and Orgyia pseudotsugata multicapsid nucleopolyhedrovirus (OpMNPV). To examine the potential role
of GP64 as a viral attachment protein in host cell receptor binding, we generated, overexpressed, and characterized a soluble form
of the OpMNPV GP64 protein, GP64solOp. Assays for trimerization, sensitivity to proteinase K, and reduction by dithiothreitol
suggested that GP64solOp was indistinguishable from the ectodomain of the wild-type OpMNPV GP64 protein. Virion binding to
host cells was analyzed by incubating virions with cells at 4°C in the presence or absence of competitors, using a single-cell
infectivity assay to measure virion binding. Purified soluble GP64 (GP64solOp) competed with a recombinant AcMNPV marker virus
for binding to host cells, similar to control competition with psoralen-inactivated wild-type AcMNPV and OpMNPV virions. A
nonspecific competitor protein did not similarly inhibit virion binding. Thus specific competition by GP64solOp for virion binding
suggests that the GP64 protein is a host cell receptor-binding protein. We also examined the kinetics of virion internalization into
endosomes and virion release from endosomes by acid-triggered membrane fusion. Using a protease sensitivity assay to measure
internalization of bound virions, we found that virions entered Spodoptera frugiperda Sf9 cells between 10 and 20 min after binding,
with a half-time of approximately 12.5 min. We used the lysosomotropic reagent ammonium chloride to examine the kinetics of
membrane fusion and nucleocapsid release from endosomes after membrane fusion. Ammonium chloride inhibition assays
indicated that AcMNPV nucleocapsids were released from endosomes between 15 and 30 min after binding, with a half-time of
approximately 25 min. © 1999 Academic Press
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(INTRODUCTION
Baculoviruses are enveloped viruses that contain
arge circular double-stranded DNA genomes ranging in
ize from ;80 to 180 kbp (Volkman et al., 1995). Tran-
cription, DNA replication, and nucleocapsid assembly
ccur within the nuclei of infected host cells. Baculovi-
uses are characterized by an infection cycle that pro-
uces two virion phenotypes, budded virus (BV) and
cclusion-derived virus (ODV), which are structurally and
unctionally distinct (reviewed in Blissard, 1996; Miller,
997; Rohrmann, 1992). BV is highly infectious in cell
ulture and mediates cell-to-cell transmission in the in-
ected animal. Virions of the second phenotype, ODV, are
mbedded within large proteinaceous occlusion bodies
hat are produced in the very late phase of the infection
ycle. Structurally, BV and ODV differ by the origin and
omposition of their envelopes (Braunagel and Sum-
ers, 1994). They also differ in the mechanisms by which
hey enter host cells. BV enters cells through the endo-
ytic pathway (Volkman and Goldsmith, 1985), whereas
1 Current address: Novagen, Inc., 601 Science Drive, Madison, WI
3711.
2 To whom reprint requests should be addressed. Fax: (607) 254-
G366. E-mail: gwb1@cornell.edu.
455DV appears to enter the midgut epithelial cells via
irect membrane fusion at the cell surface (Granados,
978; Summers, 1971). Although several studies have
xamined binding properties of the two virion pheno-
ypes (Horton and Burand, 1993; Wang et al., 1997; Wick-
am et al., 1992), the viral attachment proteins (viral
eceptor-binding proteins) and host cell receptors have
ot been identified for either ODV or BV.
The BV envelopes of Autographa californica multicapsid
ucleopolyhedrovirus (AcMNPV) and Orgyia pseudot-
ugata multicapsid nucleopolyhedrovirus (OpMNPV) con-
ain an abundant viral-encoded glycoprotein, GP64, that is
ot found in the ODV envelope (Blissard and Rohrmann,
989; Braunagel and Summers, 1994; Whitford et al., 1989).
V examined by electron microscopy contains characteris-
ic spike-like peplomers within the envelope, and these
pike proteins appear to be concentrated at the end of the
irion that is associated with virion budding. Immunoelec-
ron microscopic studies of virions budding from AcMNPV-
nfected cells suggest that the spikes are composed of the
P64 protein (Volkman, 1986), and it was recently shown
hat GP64 is necessary for efficient production of BV (Oo-
ens and Blissard, 1999). Each spike or peplomer is be-
ieved to represent a single homotrimer of the GP64 protein
Oomens et al., 1995), and antibodies directed againstP64 have been shown to neutralize infectivity of the BV
0042-6822/99 $30.00
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456 HEFFERON ET AL.Hohmann and Faulkner, 1983; Volkman et al., 1984). How-
ver, the single neutralizing monoclonal antibody (MAb
cV1) that has been characterized in detail was shown to
eutralize virion entry by inhibition of membrane fusion, a
tep after virion binding (Chernomordik et al., 1995; Volk-
an and Goldsmith, 1985). MAbs that inhibit virion binding
ave not been reported. Previous studies showed that the
P64 protein is necessary and sufficient for low pH-
riggered membrane fusion activity, the process that occurs
uring virion entry by endocytosis (Blissard and Wenz, 1992;
eikina et al., 1992), and membrane fusion has been exam-
ned in some detail (Chernomordik et al., 1995; Markovic et
l., 1998; Monsma and Blissard, 1995; Oomens and Blis-
ard, 1999; Plonsky et al., 1999; Plonsky and Zimmerberg,
996). By generating and examining a GP64-null virus con-
aining a gp64 knockout, it was demonstrated that GP64 is
n essential viral structural protein of AcMNPV (Monsma et
l., 1996). In animals fed occlusion bodies from the GP64-
ull virus (vAc64Z), midgut cells were efficiently infected by
DV, but the infection was unable to move from the midgut
pithelium into cells and tissues of the hemocoel. Similarly,
nfection by vAc64Z did not spread from cell to cell in tissue
ulture. Subsequent studies showed that GP64 is required
or efficient virion budding from the cell surface (Oomens
nd Blissard, 1999).
Envelope proteins from animal viruses mediate entry into
ost cells by facilitating two critical functions: binding to
ost cell receptors and fusion of the viral envelope with the
ost cell plasma membrane. In some cases, such as the
ell studied influenza hemagglutinin (HA) protein, both
unctions are provided by a single protein. In other cases,
uch as the parainfluenza viruses, these two functions are
egregated into two proteins: hemagglutinin/neuramini-
ase (HN) and fusion (F) proteins. Viral binding to a host
ell receptor may serve two major functions. First, adhesion
f the virus particle to the cell may be a necessary prereq-
isite for subsequent endocytosis. Second, the viral enve-
ope and host plasma membrane must be closely apposed
o fuse. In some parainfluenza viruses, it has been demon-
trated that the receptor-binding activity of the HN protein is
ecessary for fusion induced by the F protein (Lamb, 1993).
n the case of the baculoviruses OpMNPV and AcMNPV,
he GP64 protein was previously demonstrated to encode a
ow-pH-activated membrane fusion activity (Blissard and
enz, 1992). However, host cell receptor binding has not
een previously assigned to GP64 or any other BV enve-
ope protein. A recent study of GP64 glycosylation mutants
howed that decreased infectivity was observed when
ome glycosylation sites were eliminated, suggesting that
he GP64 glycosylation state may affect virion binding
Jarvis et al., 1998). Perhaps most compelling is the obser-
ation that a closely related orthomyxovirus homolog of
P64 (the GP75 protein of the Thogoto virus) has hemag-
lutination activity (Morse et al., 1992; Portela et al., 1992).
ecause the GP64 protein contains primary sequence sim- wlarities across the entire predicted ectodomain of GP75,
his suggests that the GP64 protein may also encode a
eceptor-binding function. In the present study, we exam-
ned the role of GP64 in virion binding at the cell surface. To
etermine whether GP64 was involved in virion binding to
ost cell receptors, we first generated, purified, and char-
cterized a secreted soluble form of the GP64 protein,
P64solOp. It was previously demonstrated that GP64solOp
as trimerized in a manner indistinguishable from native
embrane-bound GP64 protein (Oomens et al., 1995). In
he current study, we used N-terminal sequencing, limited
roteolysis, and dithiothreitol (DTT) sensitivity assays to
urther demonstrate that GP64solOp is indistinguishable
rom the predicted ectodomain of native GP64. Using puri-
ied GP64solOp as a competitor for virion binding to Spo-
optera frugiperda Sf9 cells, we show that GP64solOp com-
etes for binding of AcMNPV BV at the surface. To further
haracterize virion entry, we also examined the kinetics of
V entry by measuring the timing of BV internalization into
ndosomes and release of nucleocapsids from endo-
omes.
RESULTS
roduction of a secreted soluble form of GP64
A secreted soluble form of the OpMNPV GP64 protein
as produced in an AcMNPV baculovirus expression vec-
or system by insertion of a modified gp64 ORF into the
olyhedrin locus of AcMNPV. Site-directed mutagenesis
as used to insert a stop codon after Leu477, which is
ocated immediately upstream of the predicted transmem-
rane domain of the OpMNPV gp64 ORF (Fig. 1A). The
esulting construct was placed under the control of the
olyhedrin promoter in transfer vector pAcDZ1 (Jansen et
l., 1991), and a recombinant baculovirus was generated
rom BacPAK6 viral DNA. The secreted soluble form of
P64 (GP64solOp) was purified from supernatant collected
rom infected BTI-Tn-5B1–4 (High Five) cells at 48 h postin-
ection (p.i.) as described in Materials and Methods. Quan-
ity and purity of GP64solOp were assessed by Bradford
rotein assay and by Coomassie blue and silver staining of
P64solOp electrophoresed on SDS-polyacrylamide gels,
ollowed by densitometric scanning of stained gels (Fig.
B). Extensive purification of GP64solOp resulted in a prep-
ration exceeding (93–95%) purity, which was used for all
ompetition studies. A partially purified preparation of
P64solOp was used for protease resistance and oligomer-
zation studies. We previously showed that secreted soluble
P64solOp was trimerized in a manner indistinguishable
rom native OpMNPV GP64, suggesting that GP64solOp was
dentical to the ectodomain of native GP64 (Oomens et al.,
995). To further confirm the native structure and process-
ng of GP64solOp, we examined GP64solOp by N-terminal
equencing, endoglycosidase treatment, partial reduction
ith DTT, and protease treatment (below). For these stud-
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457BACULOVIRUS BINDING AND ENTRYes, GP64solOp was compared with GP64 derived from
pMNPV virions (Figs. 1 and 2).
osttranslational modifications
The N-termini of baculovirus GP64 proteins are highly
FIG. 1. (A) Construction of GP64solOp. The OpMNPV GP64 open read
nd below the bar. The gene encoding the secreted soluble form o
mmediately upstream of the transmembrane domain (TM). The N-term
ndicated below the nucleotide sequence and the predicted N-terminal
ndicates signal peptide; F, fusion domain; Helix, predicted amphipathi
ighly purified GP64solOp (purified as described in Materials and M
DS–PAGE and Coomassie blue staining. Lane 1 indicates protein mark
lycosylation. Purified GP64solOp (undigested, U) was compared with
DS–polyacrylamide gels stained with Coomassie blue. The positions o
eft, and the positions of major products of each digest are indicatedydrophobic although not well conserved in primary se- fuence (Blissard and Rohrmann, 1989; Hill and Faulkner,
994; Whitford et al., 1989). This is consistent with the
resence of a signal peptide that is cleaved during entry
nto the secretory pathway. In a previous study (Blissard
nd Rohrmann, 1989), the signal peptide cleavage site
me is represented as an open bar with protein domains indicated on
(GP64solOp) contains a stop codon (*, Stop) introduced at Tyr478,
quence determined from the mature secreted soluble GP64 protein is
ce. The signal peptide cleavage site is indicated by an arrowhead. SP
ical region; AcV5, MAb epitope; and CTD, cytoplasmic tail domain. (B)
) was compared with GP64 from OpMNPV budded virions (BV) by
e 2, OpMNPV BV; and lane 3, highly purified GP64solOp. (C) GP64solOp
lycosidase F (F)- or endoglycosidase H (H)-digested GP64solOp on
in markers and the mature GP64solOp (arrowhead) are indicated on the
right.ing fra
f GP64
inal se
sequen
c a-hel
ethods
ers; lan
endog
f proteor the OpMNPV GP64 protein was predicted at a posi-
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458 HEFFERON ET AL.ion between amino acids 17 and 18 (Fig. 1A), and this
orresponds to a similar position (between amino acids
0 and 21) in the AcMNPV GP64 protein. N-terminal
equencing of highly purified GP64solOp resulted in the
ollowing N-terminal sequence, N-Ala-Glu-His-Xxx-Asn-
la-Gln, demonstrating that the predicted peptide cleav-
ge site is correct (Fig. 1A, arrowhead).
The native AcMNPV and OpMNPV GP64 proteins con-
ain five and seven potential sites for N-linked glycosyl-
tion, respectively, and previous studies have shown that
he native proteins contain ;6–8 kDa of N-linked carbo-
ydrate per monomer (Blissard and Rohrmann, 1989;
arvis and Garcia, 1994; Oomens et al., 1995; Whitford et
l., 1989). In SDS-PAGE gels, GP64solOp migrates with a
obility similar to (or slightly smaller than) that of the
ative GP64 protein (Fig. 1B). Digestion of purified
P64solOp with endoglycosidase F or endoglycosidase H
esulted in increased mobility consistent with that re-
orted from native OpMNPV GP64 (Fig. 1C) (Oomens et
l., 1995).
roteinase K digestion and DTT reduction
To determine whether the secreted soluble form of
P64 retained a native conformation, GP64solOp was
ompared directly with GP64 from OpMNPV BV in pro-
einase K resistance assays and DTT reduction assays
Fig. 2). Previous studies of GP64 from AcMNPV virions
howed that proteinase K digestion of native GP64 re-
FIG. 2. (A) Protease resistance of OpMNPV GP64 and GP64solOp.
roteinase K (Prot.K) for 10 min at 56°C and then examined by Western
irions; lane 2, OpMNPV BV digested with proteinase K; lane 3, undiges
f the protease resistant C-terminal fragment of GP64 is indicated by t
P64solOp and wild-type GP64 (wt GP64) from OpMNPV budded virion
repared under nonreducing conditions and electrophoresed on SDS–
ere treated with increasing concentrations of DTT (0–10 mM). GP64 p
ndicate OpMNPV BV; and lanes 6–10, GP64solOp. Concentrations of D
trimers I and II, dimer, monomer) that were characterized previously (ulted in protease resistant peptides of ;34–37 kDa sVolkman and Goldsmith, 1988). To examine protease
esistance, we used an MAb (AcV5) that recognizes a
efined, conserved linear epitope near the C-terminus of
he GP64 ectodomain (Monsma and Blissard, 1995).
hen digested with proteinase K, a ;34-kDa protease-
esistant peptide (that encompasses the C-terminal por-
ion of GP64) was identified from both wild-type OpMNPV
P64 and GP64solOp (Fig. 2A, lanes 2 and 4, respec-
ively). These proteinase resistance data strongly sug-
est that analogous portions of both proteins are ex-
osed to cleavage by proteinase K and that GP64solOp is
ound in the same conformation as native GP64 from BV.
GP64 is present in BV as disulfide-linked homotrimers,
nd a previous study demonstrated that two electro-
horetic forms of trimeric GP64 are observed on nonre-
ucing SDS-PAGE gels (Oomens et al., 1995). The two
rimer forms were designated trimer I and trimer II. Tri-
ers I and II were also detected from GP64solOp. Thus
rimers of GP64solOp were indistinguishable from those
f wild-type GP64 derived from virions (see also Fig. 2B,
anes 1 versus 6). To confirm the similarities and further
xamine GP64 trimerization, both GP64solOp and wild-
ype OpMNPV GP64 from BV were incubated in increas-
ng concentrations of the reducing agent DTT, from 2 to
0 mM. In both cases, increasing concentrations of DTT
esulted in a gradual loss of trimeric forms. At low DTT
oncentrations (2–4 mM), trimer I appears to be more
usceptible to reduction than trimer II. This was ob-
olOp (0.5 mg) and OpMNPV BV (1 mg) were digested with 0.1 mg/ml
alysis using MAb AcV5. Lane 1 indicates undigested OpMNPV budded
4solOp; and lane 4, GP64solOp digested with proteinase K. The position
whead. (B) DTT sensitivity of OpMNPV GP64 and GP64solOp. Purified
reduced in varying concentrations of DTT at 37°C for 5 min and then
ylamide gels. Samples of GP64solOp (0.5 mg) and OpMNPV BV (1 mg)
were identified by Western blot analysis using MAb AcV5. Lanes 1–5
) are indicated above each lane of the gel. Oligomeric forms of GP64
s et al., 1995) are indicated on the left.GP64s
blot an
ted GP6
he arro
s were
polyacr
roteins
TT (mMerved for both GP64solOp and GP64 from OpMNPV BV
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459BACULOVIRUS BINDING AND ENTRYFig. 2B, lanes 2 and 3 and 7 and 8). At higher concen-
rations of DTT (10 mM), both GP64s were almost com-
letely reduced to monomers (Fig. 2B, lanes 5 and 10).
hese similarities in sensitivity to DTT suggest that
P64solOp and wild-type OpMNPV GP64 are very similar
n structure.
aculovirus BV binding and infectivity
To examine virion binding and entry in subsequent
xperiments, we used a recombinant AcMNPV virus con-
aining a lacZ gene under the control of a promoter
Drosophila hsp70) that is active early in the infection
ycle. The recombinant AcMNPV marker virus (vAchsZ)
Monsma et al., 1996; Vlak et al., 1990) was used in a
ingle-cell infectivity assay to measure changes in virion
inding. To identify assay conditions in which changes in
irion binding could be detected and quantified, we first
enerated a dose-response curve. Sf9 cells (3 3 105)
ere infected with increasing concentrations of vAchsZ
irions (m.o.i. 0.0125–0.2), by binding BV to cells at 4°C
or 1 h; then cells were washed, incubated at 27°C for
4 h, and stained for b-galactosidase expression in sin-
le infected cells. This resulted in a proportional linear
ncrease in the number of single infected cells detected
rom increasing concentrations of virions (Fig. 3A). Thus
ithin this range of virion concentrations and under
hese conditions, virions are not present in saturating
oncentrations; therefore, competition for virion binding
an be more readily detected by this method. Virion
oncentrations within the linear range of this assay were
sed in all subsequent experiments.
In these studies, virion entry was synchronized by
inding BV to cells at 4°C for 1 h and then shifting the
emperature to 27°C to permit endocytosis of virions. To
onfirm that the vAchsZ BV bound at 4°C remained at the
ell surface at the end of the 1-h binding period, virions
ere bound to cells at 4°C for 1 h and then cells were
ashed and treated with the protease subtilysin to inac-
ivate or release virions at the cell surface. As a control,
irions were bound to cells at 4°C for 1 h, washed in
NM-FH medium, and then incubated at 27°C for 1 h
allowing bound virions to internalize) and subsequently
reated with subtilysin. Treatment of cells with subtilysin
mmediately after the 4°C binding step resulted in a
ramatic decrease in numbers of infected cells detected
Fig. 3B, column 2). In contrast, when virions were bound
t 4°C and then allowed to enter endosomes by incu-
ating at 27°C for 1 h before subtilysin treatment, no
etectable decrease in infectivity was observed (column
). A control pretreatment of BV with subtilysin before
inding (column 4) resulted in little binding and infectiv-
ty, as expected. These data indicate that during the 4°C
ncubation period, virions remain at the cell surface, and
hat bound virions enter within 1 h after the shift from 4°C bFIG. 3. (A) Dose-response curve for a single-cell infectivity as-
ay with virus vAchsZ. To develop a rapid single-cell infectivity
ssay for detecting changes in virion binding, a range of virion
oncentrations were examined in a 1-h viral binding assay. To
dentify a range of virion concentrations in which the response
o increasing virion concentrations was linear, Sf9 cells (3 3 105)
ere incubated with increasing concentrations of vAchsZ (m.o.i.
.0125–0.2) for 1 h at 4°C and then washed in TNM-FH and incu-
ated for 24 h in TNM-FH at 27°C. Single cells were scored for
xpression of b-galactosidase as described in the Materials and
ethods. In the dose-response curve, each data point represents
he averaged results from three wells, and bars represent standard
eviation. (B) Protease sensitivity of virions bound at the cell sur-
ace. To determine whether virions remained at the cell surface at
he end of a 1-h binding period at 4°C, the sensitivity of surface-
ound virions to inactivation or release by treatment with the pro-
ease subtilysin was examined in a single-cell infection assay.
irions of vAchsZ were bound to Sf9 cells at 4°C for 1 h and then
ells were washed 33 with TNM-FH at 4°C and either not treated
lane 1) or treated with 2 mg/ml subtilysin (lane 2) before shifting to
7°C and incubating for 24 h. As a control, virions were bound at
°C, cells were washed as above, and then virions were allowed to
nternalize by shifting to 27°C for 1 h before treatment with subtilysin
lane 3). Control vAchsZ virions were pretreated with subtilysin
efore binding and analysis in the single-cell infection assay (lane
). Each data point represents average data from three wells, and
ars represent standard deviation.
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460 HEFFERON ET AL.o 27°C. Thus entry by endocytosis (after binding) is
fficiently synchronized in this manner.
irion and GP64solOp competition
Because GP64 is the major envelope protein of the BV,
e hypothesized that BV binding to the host cell receptor
ay be mediated by GP64. The OpMNPV and AcMNPV
P64 proteins are highly conserved, showing 84% se-
uence identity in the ectodomains. In addition, in previous
tudies (unpublished), we found that OpMNPV BV appears
o bind and enter Sf9 cells, although Sf9 cells are not
ermissive for OpMNPV replication. Thus if the GP64 pro-
ein encodes the host cell receptor-binding activity, the
pMNPV GP64 protein may compete for the same binding
ites used by AcMNPV or the AcMNPV recombinant,
AchsZ. To determine whether OpMNPV virions compete
or the same binding sites used by AcMNPV, psoralen-
nactivated virions of AcMNPV and OpMNPV were used as
ompetitors in the virion-binding assay described above.
or these competition assays, Sf9 cells were incubated for
.5 h at 4°C with various concentrations of psoralen-
nactivated AcMNPV or OpMNPV virions before the addi-
ion and binding of vAchsZ at 4°C for 1 h. Prebinding of
soralen-inactivated AcMNPV or OpMNPV virions at 4°C
esulted in a dramatic decrease in the number of cells
nfected by vAchsZ, as detected in the single-cell infectivity
ssay (Fig. 4). Results of these competition assays suggest
hat both AcMNPV and OpMNPV virions competed with
AchsZ for binding sites on Sf9 cells.
ompetition studies with a soluble GP64 protein
Because both AcMNPV and OpMNPV appeared to
ompete for the same host cell receptor sites, we next
sked whether secreted soluble GP64 (GP64solOp) would
imilarly compete for binding to the host cell receptor. To
ddress this question, varying concentrations of
P64solOp were incubated with Sf9 cells at 4°C for 1.5 h,
nd then vAchsZ was added and bound to cells for an
dditional hour at 4°C. As a control, identical molar
oncentrations of BSA were included in a parallel com-
etition assay. Incubation of cells with increasing con-
entrations of GP64solOp resulted in a dramatic decrease
n the number of infected cells (Fig. 5). Inhibition of virion
inding was first detected at a GP64solOp concentration
f 50 nM and was further inhibited by increasing con-
entrations of GP64solOp (100 and 200 nM). Only a minor
eduction in the numbers of infected cells was observed
hen equivalent concentrations of BSA were used as a
onspecific competitor (Fig. 5, dashed line). Competition
y GP64solOp for virion binding was observed in at least
ix separate experiments. To determine whether native
P64solOp trimers were required for efficient binding and
s a further control to confirm the role of GP64, purified
P64solOp trimers were reduced by treatment in 10 mM bTT before competition assays. Previous studies
howed that these conditions were sufficient to reduce
rimeric GP64solOp to monomers (Fig. 2B). For these
xperiments, concentrated GP64solOp was reduced in 10
M DTT and then diluted to a final concentration of 50
M GP64solOp and 0.1 mM DTT for use as a competitor.
he treatment of GP64solOp with 10 mM DTT resulted in
loss of competition by GP64solOp (Fig. 6). In a mock
xperiment, the same final dilution of DTT (0.1 mM DTT)
dded alone to cells did not affect infection in the ab-
ence of the competitor (not shown). The inability of
educed GP64solOp to effectively compete for virion-
inding sites suggests that disulfide bonds may be nec-
ssary for maintenance of a receptor-binding domain of
P64 or that native trimeric GP64 is necessary for effi-
ient receptor binding by GP64 (Fig. 6). As an additional
ontrol, GP64solOp was also pretreated with chymotryp-
in, followed by protease inhibitors, before use in com-
etition assays. Protease-treated GP64solOp did not com-
ete for binding by vAchsZ (Fig. 6).
inetics of virion entry
The timing of BV entry into endosomes was measured
FIG. 4. Competition for virion binding by inactivated AcMNPV and
pMNPV BV. To determine whether OpMNPV and AcMNPV BV utilize
he same host receptor-binding sites on Sf9 cells, psoralen-inactivated
V of AcMNPV and OpMNPV was used as competitors for binding of
V from vAchsZ. Sf9 cells were preincubated with increasing concen-
rations of psoralen-treated AcMNPV and OpMNPV BV (X-axis, m.o.i.) at
°C for 1 h. The X-axis represents the quantity of BV corresponding to
he indicated m.o.i. before psoralen inactivation. After prebinding of
soralen-inactivated BV (AcMNPV or OpMNPV), vAchsZ was added
nd allowed to bind for 1 h at 4°C. Cells were washed in TNM-FH, fresh
edium was added, and infection was allowed to proceed for 20 h.
umbers of infected cells were determined as described in Materials
nd Methods. Each data point represents average data from three
ells, and bars represent standard deviation.y first synchronizing BV binding at the cell surface at
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461BACULOVIRUS BINDING AND ENTRY°C, incubating for various periods at 27°C to permit
ndocytosis, inactivating or releasing BV remaining at
he cell surface with subtilysin treatment, and then mea-
uring the virus that was internalized and therefore pro-
ected from subtilysin treatment. For these studies, we
sed virus vAchsZ and the single-cell infectivity assay
escribed above. vAchsZ was bound to cells for 1 h at
°C. and then the temperature was shifted to 27°C for
ncreasing intervals of time (0–90 min). At the end of each
ime interval, cells were treated with 2 mg/ml subtilysin
o inactivate or release BV remaining at the cell surface.
ells were washed and then incubated at 27°C for 24 h,
nd the numbers of infected cells were determined as
escribed earlier. The protease resistance curve shown
n Fig. 7A (solid line) shows that between 0 and 10 min at
7°C, BV were highly sensitive to inactivation by exog-
nously applied subtilysin. Resistance to inactivation by
ubtilysin increased dramatically between 10 and 20 min
FIG. 5. GP64solOp competition for AcMNPV binding. GP64solOp was
escribed earlier. Sf9 cells were preincubated with increasing concent
.5 h, and then vAchsZ virions were added and bound for 1 h at 4°C.
ssayed for single-cell infectivity. The numbers of infected cells (Y-axi
epresents average data from two wells, and bars represent standardf incubation at 27°C. As shown in Fig. 7A, the measured calf-time for internalization of virions into endosomes
as ;12.5 min.
Release of BV nucleocapsids from the endosome oc-
urs when the BV envelope fuses with the membrane of
he endosome, an event catalyzed by the pH-triggered
usion activity of GP64. Studies using a syncytium forma-
ion assay indicate that AcMNPV and OpMNPV GP64s
re triggered at pH values of ;5.5–5.7 (Blissard and
enz, 1992; Leikina et al., 1992). Lipophilic amines such
s ammonium chloride or chloroquine buffer the endo-
omal pH and can be used to inhibit membrane fusion
uring endocytosis. For precise studies of timing, ammo-
ium chloride appears to be the reagent of choice be-
ause ammonium chloride can buffer the pH of the
ndosome within 1 min after its addition to cells (Greber
t al., 1993). To measure the timing of baculovirus nu-
leocapsid release from the endosome, we used ammo-
ium chloride inhibition in combination with the single-
as a competitor for virion binding in a single-cell infectivity assay as
(X-axis) of either GP64solOp (solid line) or BSA (dashed line) at 4°C for
ere washed at 4°C in PBS and then incubated at 27°C for 22 h and
quantified as described in Materials and Methods. Each data point
on.used
rations
Cells w
s) wereell infectivity assay. vAchsZ BV binding at the cell sur-
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462 HEFFERON ET AL.ace was synchronized by binding virions at 4°C for 1 h
nd then shifting the cells to 27°C. After various intervals
t 27°C (0–120 min), ammonium chloride was added to a
inal concentration of 25 mM, and cells were incubated
or up to 24 h. At 24 h after shifting to 27°C, plates were
cored for infected cells. When ammonium chloride was
dded immediately after the 4°C BV-binding period, a
98% inhibition of virion infectivity was observed. With
ncreasing intervals of incubation at 27°C before ammo-
ium chloride addition, the numbers of infected cells that
ere detected increased (Fig. 7B). Escape from ammo-
ium chloride inhibition was first detected after 16 min
nd was near maximal levels after ;28–30 min of incu-
ation at 27°C. Within 30 min at 27°C, infectivity had
ncreased to ;90% of that from cells in which no ammo-
ium chloride was added. Thus after binding of BV at the
ell surface, the estimated half-time for triggering of
embrane fusion and release of BV nucleocapsids from
he endosome in Sf9 cells was ;25 min (Fig. 7B).
DISCUSSION
The process of baculovirus entry by receptor-mediated
FIG. 6. Reduction in specific competition by GP64solOp after treat-
ent with protease or reducing agent. GP64solOp was treated with
ither 1 mg/ml chymotrypsin (hatched bars) or 10 mM DTT (open bars)
efore use as a competitor in a virion-binding assay, as in Fig. 5.
ompetitor (GP64solOp or BSA) concentrations were 50 nM; a control
ompetitor, BSA, was similarly treated. Treated and untreated protein
ompetitors were preincubated with Sf9 cells at 4°C for 1.5 h before
ncubation with BV of vAchsZ and detection of single-cell infectivity as
escribed in the legend to Fig. 5 and Materials and Methods. Bars
ndicate numbers of infected cells, and each bar represents the aver-
ge data from three wells. Error bars represent standard deviation.ndocytosis may be subdivided into several discrete bteps: virion binding at the cell surface, formation of
lathrin coated pits and uptake of the virion into a vesicle
endosome), triggering of membrane fusion by low pH,
nd release of the nucleocapsid into the cytoplasm.
lthough the role of GP64 in membrane fusion has been
xamined in some detail (Blissard and Wenz, 1992; Cher-
omordik et al., 1995; Markovic et al., 1998; Monsma and
lissard, 1995; Monsma et al., 1996; Plonsky et al., 1999,
997), its role as a potential host cell receptor-binding
rotein has not been previously explored. Several lines
f indirect evidence suggested that GP64 might repre-
ent the viral encoded host cell receptor-binding protein.
irst, the GP64 protein represents the most abundant
iral protein identified from the BV envelope, and BV-
eutralizing antibodies recognize the GP64 protein (Ho-
mann and Faulkner, 1983; Roberts and Manning, 1993).
ecent studies of GP64 glycosylation also suggested
hat the glycosylation state of GP64 may affect virion
inding to host cells (Jarvis et al., 1998). Second, GP64
omologs (known as GP75) from a small group of arbo-
iruses within the Orthomyxoviridae appear to be in-
olved in receptor binding. The GP75 proteins from the
hogoto and Dhori viruses show remarkable primary
mino acid sequence identity with baculovirus GP64
roteins, and Thogoto virus hemagglutination is inhibited
y an MAb directed against GP75 (Leahy et al., 1997;
orse et al., 1992; Portela et al., 1992). Finally, the GP64
rotein expressed on the surface of transfected insect
ells is capable of mediating low pH-triggered mem-
rane fusion (Blissard and Wenz, 1992). Because prior
eceptor binding (docking) is usually a requirement for
embrane fusion, this final observation strongly sug-
ested that GP64 may also function as the host cell
eceptor-binding protein.
In the current study, we examined the role of GP64 in
ost cell receptor binding by using a soluble form of
pMNPV GP64 as a competitor for virion binding. To
xamine competition for virion binding to the host cell,
e developed a competition assay in which a recombi-
ant baculovirus (vAchsZ) carrying a marker gene was
ound to the cell surface by incubation at 4°C in the
resence of competitor proteins. Unbound virions were
emoved by washing cells before shifting the tempera-
ure to 27°C. Successful virus binding was scored by
nalysis of single-cell expression of b-galactosidase
rom the recombinant virus. In competition experiments,
e showed that both AcMNPV and OpMNPV competed
ith vAchsZ for binding, suggesting that OpMNPV and
cMNPV utilize the same cellular receptor or receptors.
o examine the role of GP64 in virion binding to host
ells, we used a highly purified soluble form of GP64 as
direct competitor for virion binding. The purified soluble
P64 (GP64solOp) was determined to be structurally in-
istinguishable from the ectodomain of native GP64 from
udded virions, based on oligomerization patterns and
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463BACULOVIRUS BINDING AND ENTRYheir comparative sensitivities to glycosidase, protease
leavage, and reducing agent DTT. Because the soluble
orm of GP64 specifically competed for vAchsZ binding to
f9 cells, these data directly implicate GP64 as a host
ell receptor-binding protein. In addition, reduced
P64solOp did not exhibit any significant competition in
his assay, suggesting that disulfide bonds may be im-
ortant in maintaining a structure capable of efficiently
inding the receptor. Although we did not attempt to
easure the affinity of GP64solOp binding to host cells in
he current study, it is likely that GP64solOp binds to host
ells with a lower overall affinity than virions, which
ontain local concentrations of GP64. Such differences
n affinity may explain why we were not able to eliminate
irion binding completely in this very sensitive assay.
owever, the observation that GP64solOp competes for
FIG. 7. (A) Kinetics of virion internalization into endosomes. The kinet
inding vAchsZ BV to the cell surface of Sf9 cells at 4°C for 1 h and t
esistance of internalized BV to inactivation by subtilysin was measur
irions of vAchsZ were incubated at 27°C for time periods of 5–90 min
nd incubated at 27°C for 24 h. Numbers of infected cells were determ
he average of three wells. Error bars represent standard deviation. S
inetics of nucleocapsid release from the endosome. The kinetics of nu
after binding) required to acquire resistance to inhibitors of endosoma
or 1 h at 4°C, and then the temperature was shifted to 27°C for increas
ith medium containing 25 mM ammonium chloride for the remaind
escribed above. The inset shows an identical experiment in which airion binding in this assay provides the most compelling vata to date that GP64 serves as a baculovirus attach-
ent protein.
gp64 genes from several baculoviruses (AcMNPV, BmNPV,
pMNPV, and CfMNPV) have been identified, and these
roteins are highly conserved, showing approximately
0% amino acid sequence identity between the predicted
ctodomains (Blissard and Rohrmann, 1989; Hill and
aulkner, 1994; Majima et al., 1996; Whitford et al., 1989).
ecause both AcMNPV and OpMNPV are able to enter
podoptera frugiperda cell lines yet are distinctly differ-
nt viruses with distinct host ranges, the differences in
ost range may be explained by factors other than virion
inding. Indeed, our previous studies have shown that
wo OpMNPV late promoters are not fully functional in
he AcMNPV genome (Garrity et al., 1997). Studies of
ost range determinants in AcMNPV and other baculo-
irion internalization into endosomes were examined by synchronously
ifting to 27°C for various periods of time and treating with subtilysin.
he single-cell infection assay described earlier. Synchronously bound
end of each time period, cells were treated with subtilysin, washed,
described in Materials and Methods, and each data point represents
in-treated cells (solid line); untreated control cells (dashed line). (B)
sid release from the endosome were examined by measuring the time
rane fusion. Virions of vAchsZ were synchronously bound to Sf9 cells
periods (2–120 min). At the end of each period, medium was replaced
e assay (24 h). The numbers of infected cells were determined as
m chloride was added at 2-min intervals between 0 and 40 min.ics of v
hen sh
ed by t
. At the
ined as
ubtilys
cleocap
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464 HEFFERON ET AL.ot appear to be associated with virion entry into the
ost cell (Croizier et al., 1994; Du and Thiem, 1997;
amita and Maeda, 1993; Lu and Miller, 1996; Maeda et
l., 1993; Miller and Lu, 1997). Those studies indicate that
aculovirus host specificity can be determined at levels
ther than virion binding at the cell surface. However,
dentification of the host receptor for AcMNPV BV will be
mportant for understanding whether viral entry may in-
luence tissue specificity within the infected host and for
pplications of AcMNPV BV for gene delivery in biotech-
ological applications such as gene therapy. BV from
cMNPV are infectious to cells of many insect tissues
nd are highly infectious in insect cell culture. Several
arly studies showed that BV entered cells of diverse
rganisms that were nonpermissive for viral replication
Brusca et al., 1986; Carbonell and Miller, 1987), although
he mechanisms of entry were not examined. Recent
tudies of several mammalian cell types showed that
cMNPV BV efficiently entered primary cultures of hu-
an hepatocytes and cell lines derived from hepatocytes
Barsoum et al., 1997; Boyce and Bucher, 1996; Hofmann
t al., 1995; Sandig et al., 1996). Other recent studies
ave reported BV entry into a broad range of mammalian
ell lines (Condreay et al., 1999; Shoji et al., 1997). The ap-
arently wide array of potential cell types that AcMNPV
V can enter suggests that the BV interaction with the
ost cell may involve recognition of a host receptor
olecule that is highly conserved and present on many
ell types or that the interaction may be relatively non-
pecific.
In the current study, we also examined the kinetics of
wo successive steps in baculovirus BV entry by recep-
or-mediated endocytosis: (1) uptake into the endosome
nd (2) release from the endosome by membrane fusion.
AchsZ entry was analyzed by synchronizing BV entry by
inding virions to cells at 4°C and then using a protease
esistance assay to measure virions internalized after
arious periods of incubation at 27°C. The measured
alf-time required for virus uptake was 12.5 min. This rate
f entry is similar to those reported from influenza virus,
denovirus, and SFV, which have uptake half-times of
2.5, 10, and 5–10 min, respectively (Greber et al., 1993;
arsh and Helenius, 1989; Martin and Helenius, 1991).
elease of baculovirus virions from endosomes was
easured using an inhibitor of low-pH-triggered mem-
rane fusion. The measured half-time for nucleocapsid
elease from the endosome was ;25 min. This is similar
o release times reported from several enveloped vi-
uses, including influenza, VSV, and West Nile virus (Gol-
ins and Porterfield, 1986; Marsh and Helenius, 1989;
atlin et al., 1982). In an earlier study (Volkman and
oldsmith, 1985), it was estimated that significantly
onger times (half-times of 1–1.5 h) were necessary for
cMNPV BV release from the endosome. The differ-
nces may result from differences in the assay tech- Biques used in the two studies. In the current study, we
sed a sensitive single-cell infectivity assay that detects
iral entry and early gene expression in single cells, thus
solating virion entry from subsequent steps such as late
ene expression, viral replication, and plaque formation.
he current data on BV entry and nucleocapsid release
orrespond well with data reported from other enveloped
iruses.
In summary, we identified GP64 as a protein involved
n AcMNPV binding to host cell receptors, and we char-
cterized two steps in AcMNPV entry into host cells:
nternalization into and release from endosomes. Be-
ause the GP64 proteins are highly conserved in several
aculoviruses and share a common ancestry with the
P75 envelope proteins from several orthomyxoviruses
hat are transmitted by ticks, it is possible that a common
ntry mechanism is shared by these disparate groups
hat both infect arthropods. Future studies that identify
nd characterize the host cell receptor for baculovirus
inding will be important for understanding how these
ery different viruses are adapted to their invertebrate
osts.
MATERIALS AND METHODS
ells, viruses, and recombinant virus construction
Spodoptera frugiperda (Sf9) and Lymantria dispar
Ld652Y) cells were cultured at 27°C in TNM-FH com-
lete medium (Hink, 1970) containing 10% FBS. Viruses
cMNPV (strain E2) and vAchsZ (Monsma et al., 1996;
lak et al., 1990) were titered on Sf9 cells, and OpMNPV
as titered on Ld652Y cells as described previously
Blissard and Rohrmann, 1989). To construct a recombi-
ant virus expressing soluble GP64, a stop codon was
ngineered into the OpMNPV gp64 gene in plasmid
64-166 (Blissard and Wenz, 1992) immediately upstream
f the predicted transmembrane domain. A synthetic
ligonucleotide (59-CTCAACGCCACGCTCTgaTCATTTAT-
CTGGGGCAC-39) was used to convert the codon for
yr478 (TAC) to TGA, using site-directed mutagenesis
Deng and Nickoloff, 1992; Ray and Nickoloff, 1992). Next,
he synthetic antisense oligonucleotide 59-ACCATCTG-
AGATCTTGTAGTGTT-39 was used for site-directed mu-
agenesis to introduce a BglII restriction site just up-
tream of the gp64 ATG, and the resulting plasmid was
amed p64-BglATG-STOP. The ;1700-bp BglII–SpeI frag-
ent containing the gp64 ORF from p64-BglATG-STOP
as cloned into BamHI–XbaI-digested transfer vector
AcDZ1, replacing the lacZ ORF and placing the modified
p64 ORF under control of the very late polyhedrin pro-
oter. The resulting plasmid was named (pAcGP64STOP).
recombinant virus was generated by cotransfection of
f9 cells with pAcGP64STOP and Bsu36I-digested
acPAK6 viral genomic DNA (Clontech), and the virus
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465BACULOVIRUS BINDING AND ENTRYas named vAcGP64solOp. This virus was also referred
o as EFPsolC2 in a previous report, and the soluble
rotein expressed from this virus (GP64solOp) was also
eferred to earlier as GP64EFPsol (Oomens et al., 1995).
ecombinant viruses were isolated by three rounds of
imiting-dilution cloning. Recombinant viral genomes
ere confirmed by restriction enzyme analysis and by
CR using primers homologous to the polyhedrin pro-
oter and the OpMNPV gp64 gene.
urification of GP64solOp
For biochemical studies requiring high purity GP64solOp
nd to confirm biological assays, a highly purified prep-
ration of GP64solOp was prepared. A four-step protocol
as developed to purify GP64solOp from tissue culture
upernatants of vAcGP64solOp-infected cells. Insect cells
BTI-Tn-5B1–4) were grown in serum-free media (Excell
05; JRH Biosciences) and infected at an m.o.i. of 10 with
AcGP64solOp. After infection, the cells were diluted to a
ensity of 1 3 106 cells/ml and maintained in spinner
ulture at 27°C for 48 h. Cells and debris were removed
y low-speed centrifugation, supernatants were col-
ected, and sodium azide was added to 0.02% w/v. So-
ium azide was present at all times throughout the pu-
ification, except for ion-exchange loading, wash, and
lution. ConA-agarose beads (Sigma) equilibrated in
onA wash buffer (150 mM NaCl, 20 mM NaH2PO4, pH
.0) were added to the supernatant (;143 mg beads/liter)
nd mixed gently overnight at ;4 rpm at 7°C in a roller
ottle. The beads were collected in a large buchner
unnel, transferred to a glass column (3-cm diameter),
nd washed extensively with ConA wash buffer. Bound
lycoproteins were eluted with two bed volumes of 0.5 M
lucose, 0.5 M methyl-D-mannopyranoside, and 20 mM
aH2PO4, pH 7.0, followed by three bed volumes of ConA
ash buffer. The eluate and first bed volume of wash
ere pooled and dialyzed overnight against 200 mM
aCl and 20 mM NaH2PO4, pH 7.0. The dialyzed pool
as centrifuged (27,000g for 30 min at 4°C) to remove
recipitated materia. For hydrophobic interaction chro-
atography, the supernatant was applied to a column
omposed of phenyl–Sepharose CL-4B equilibrated with
00 mM NaCl and 20 mM NaH2PO4, pH 7.0. After sample
pplication, the column was washed with one bed vol-
me of 200 mM NaCl and 20 mM NaH2PO4, pH 7.0,
ollowed by one bed volume of 20 mM Tris–HCl, pH 8.0.
he bound proteins were eluted by washing with two bed
olumes of distilled H2O. The bound GP64sol
Op eluted as
major peak at the 20 mM Tris–HCl–dH2O transition,
ollowed by a very broad tail. The fractions were ana-
yzed on SDS–polyacrylamide gels, and the fractions
ontaining GP64solOp were pooled and dialyzed against
0 mM Tris–HCl, pH 8.0. For anion-exchange chromatog-
aphy, the pooled fractions were applied to a DEAE- pemsep cartridge (Millipore) equilibrated with 20 mM
ris–HCl, pH 8.0. After sample application, the cartridge
as washed with 20 mM Tris–HCl, pH 8.0. Bound pro-
eins were eluted with a linear salt gradient (0–250 mM
aCl) in 20 mM Tris–HCl, pH 8.0. GP64solOp eluted as
everal peaks at salt concentrations from 75 to 150 mM
aCl. The fractions containing GP64solOp were pooled,
nd Tween 20 was added to 0.1% vol/vol and sodium
zide was added to 0.02% wt/vol. The pooled fractions
ere concentrated with Centriprep 30k MWCO ultrafil-
ration units. For gel filtration chromatography, the con-
entrated fractions were applied to a 94-cm 3 2-cm
olumn of Sephacryl S400HR equilibrated with 200 mM
aCl and 20 mM NaH2PO4, pH 7.0. The peak fractions
ontaining GP64solOp were pooled and concentrated as
bove, and aliquots of GP64solOp were stored at 280°C.
he final purity of GP64solOp was $95% as judged by
ensitometric quantification of Coomassie blue-stained
DS–polyacrylamide gels, and typical expected yields
ere ;1–2 mg/liter of cells (at 1 3 106 cells/liter). For
rotease resistance assays, a partially purified prepara-
ion of GP64solOp was prepared and used. Supernatants
f cells infected with vAcGP64solOp were collected as
efore and incubated with ConA beads as described
bove; then protein was precipitated in 10% ammonium
ulfate. GP64solOp was further purified by gel filtration
hromatography as described above. Purity of partially
urified GP64solOp was estimated at ;60% by Bradford
ssay and Coomassie-stained SDS–polyacrylamide gels
nd confirmed by Western blot analysis.
lycosidase treatment, protease resistance, and
eduction of GP64solOp
For glycosidase digestions, 2 mg of purified GP64solOp
as digested with either 0.5 unit of Endo F (Boehringer)
r 0.01 unit of Endo H (Boehringer) for 1 h in 10 mM
odium phosphate buffer, pH 7.0, at 37°C and then elec-
rophoresed on 6% SDS–polyacrylamide gels.
To compare the protease resistance profiles of
P64solOp and native OpMNPV GP64, 0.5 mg of secreted
oluble GP64 (GP64solOp) and 1.0 mg of OpMNPV budded
irions were each treated with 0.1 mg/ml proteinase K for
0 min at 56°C. Digestion products were examined by
lectrophoresis on SDS–polyacrylamide gels and West-
rn blot analysis with MAb AcV5 (Hohmann and
aulkner, 1983). For comparisons of oligomerization and
he susceptibility of oligomers to reduction by DTT, puri-
ied GP64solOp (0.5 mg) or OpMNPV budded virions (1.0
g) were incubated with increasing concentrations of
TT at 37°C for 5 min. Trimerization and reduction were
xamined by preparing proteins in 37.5 mM iodoacet-
mide, 2% SDS (no b-mercaptoethanol), and electro-
horesing proteins on a 6% nonreducing polyacrylamide
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466 HEFFERON ET AL.el as described earlier (Oomens et al., 1995), followed
y Western blot analysis using MAb AcV5.
inding, infectivity, and competition assays
To measure the effects of GP64solOp competition on
V binding, we used recombinant virus vAchsZ (which
onstitutively expresses b-galactosidase in the early
hase) for a sensitive single-cell infectivity assay. To
emonstrate the linearity of the assay, Sf9 cells (3 3 105)
ere infected in 24-well plates with varying concentra-
ions of vAchsZ virions (m.o.i. 0.0125–0.2) by incubating
irus with cells for 1 h at 4°C. Cells were washed three
imes in complete TNM-FH medium at 4°C and then
ncubated for 24 h in complete TNM-FH medium at 27°C,
ixed 10 min in 0.5% gluteraldehyde in PBS at room
emperature, and stained for b-galactosidase activity by
ncubation in a solution of 1 mg/ml X-gal, 5 mM potas-
ium ferricyanide, 5 mM potassium ferrocyanide, and 1
M MgSO4 in 1 3 PBS, pH 7.4, as described previously
Sussman, 1995). For each virus dilution, three wells of
ells were infected, and the number of stained cells in
ach well were counted. Data presented (Fig. 3) repre-
ent the average and standard deviation (error bars) of
ata from three wells. For competition assays, Sf9 cells
3 or 6 3 105) were preincubated with varying concen-
rations of competitors for 1.5 h at 4°C; then BV of vAchsZ
as added and incubated with agitation for 1 h at 4°C,
nd cells were processed and assayed as described
bove. For some experiments, higher or lower m.o.i.
alues of vAchsZ were used, but in all cases, the values
ell within the linear range of the assay (as established
bove, Fig. 3A). Viruses (AcMNPV and OpMNPV) used as
ompetitors in binding assays were inactivated by the
ddition of psoralen (49-aminomethyl; Triosalen, Sigma).
soralen was added to virus stocks (;1 3 108 infectious
nits/ml) to a final concentration of 1 mg/ml followed by
ross-linking for 10 min with a UV transilluminator (312
m); then virus preparations were diluted to the appro-
riate concentrations and used in competition assays.
nactivation of viral infectivity was confirmed by examin-
ng infectivity on Sf9 or Ld652Y cells as described above.
For competition assays, protein competitors consisted
f highly purified GP64solOp and a negative control, BSA
Sigma Chemicals). As additional controls, protein com-
etitors were also treated with chymotrypsin (2 mg/ml) at
7°C for 30 min. Reactions were terminated with 1 mM
eupeptin, 1 mM pepstatin A, and 4 mM Pefabloc. Com-
lete proteolysis of GP64solOp was assessed by electro-
horesis and examination on 8% polyacrylamide gels. As
n additional control, DTT was added to a final concen-
ration of 10 mM, and samples were incubated at 95°C
or 20 min. After treatment in DTT, protein samples were
iluted 1003 to a final concentration of 0.1 mM DTT and
pplied to cells as competitors. To confirm that this Boncentration of DTT did not interfere with infection, cells
ere also preincubated with 0.1 mM DTT before infection
ith vAchsZ, in the absence of competition.
V binding, entry, and endocytosis assays
For analysis of virion binding at the cell surface and
ntry after binding, BV of virus vAchsZ was bound to Sf9
ells at 4°C for 1 h, and cells were washed in complete
NM-FH at 4°C. In initial experiments, subtilysin was
dded to a final concentration of 2 mg/ml either before or
fter shifting cells to 27°C and incubating for 1 h. As
ontrols, BV were also pretreated with subtilysin (2 mg/
l) before binding BV to Sf9 cells. For studies of virion
ntry, BV of vAchsZ were bound to Sf9 cells at 4°C for
h; then the temperature was shifted to 27°C for in-
reasing periods of time. At the end of each time interval
t 27°C, cells were treated with 2 mg/ml subtilysin in
BS for 15 min at 37°C to inactivate or remove virions
emaining at the cell surface. This concentration of sub-
ilysin was previously determined to inactivate BV when
V were treated before binding to host cells (not shown).
ells were then washed three times with complete
NM-FH medium, incubated for 24 h at 27°C in TNM-FH
omplete medium, and then fixed and stained as de-
cribed above and scored for single infected cells. To
xamine the kinetics of virion release from the endo-
ome, virions were bound to cells for 1 h at 4°C. The
emperature was then shifted to 27°C for increasing time
ntervals as described above. At the end of each interval,
edia was exchanged for TNM-FH containing 25 mM
mmonium chloride and then incubated 24 h at 27°C and
ssessed for single cells expressing b-galactosidase
ctivity.
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